ASNDNasdaq

Ascendis Pharma A/S

Pharmaceutical Preparations · G7 · CIK 1612042

Ascendis Pharma A/S develops and commercializes innovative therapies using its TransCon technologies

$14.30B

Market cap

$263.70

Last close

+1.1%

+15.7%

1.1M

Volume

Price · last 39 sessions+15.3%

May 4L $205.81 · H $263.70Jun 29

462

Total filings

Jun 29, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance